Literature DB >> 25842377

Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity.

John D Douglass1, Yin Xiu Zhou1, Amy Wu1, John A Zadroga1, Angela M Gajda1, Atreju I Lackey1, Wensheng Lang2, Kristen M Chevalier2, Steven W Sutton2, Sui-Po Zhang2, Christopher M Flores2, Margery A Connelly2, Judith Storch3.   

Abstract

Monoacylglycerol lipase (MGL) is a ubiquitously expressed enzyme that catalyzes the hydrolysis of monoacylglycerols (MGs) to yield FFAs and glycerol. MGL contributes to energy homeostasis through the mobilization of fat stores and also via the degradation of the endocannabinoid 2-arachidonoyl glycerol. To further examine the role of MG metabolism in energy homeostasis, MGL(-/-) mice were fed either a 10% (kilocalories) low-fat diet (LFD) or a 45% (kilocalories) high-fat diet (HFD) for 12 weeks. Profound increases of MG species in the MGL(-/-) mice compared with WT control mice were found. Weight gain over the 12 weeks was blunted in both diet groups. MGL(-/-) mice were leaner than WT mice at both baseline and after 12 weeks of LFD feeding. Circulating lipids were decreased in HFD-fed MGL(-/-) mice, as were the levels of several plasma peptides involved in glucose homeostasis and energy balance. Interestingly, MGL(-/-) mice had markedly reduced intestinal TG secretion following an oral fat challenge, suggesting delayed lipid absorption. Overall, the results indicate that global MGL deletion leads to systemic changes that produce a leaner phenotype and an improved serum metabolic profile.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  monoacylglycerol lipase; monoacylglycerols; monoglycerides

Mesh:

Substances:

Year:  2015        PMID: 25842377      PMCID: PMC4442873          DOI: 10.1194/jlr.M058586

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  75 in total

1.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.

Authors:  Michael W Rajala; Silvana Obici; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.

Authors:  S J Smith; S Cases; D R Jensen; H C Chen; E Sande; B Tow; D A Sanan; J Raber; R H Eckel; R V Farese
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Loss of resistin improves glucose homeostasis in leptin deficiency.

Authors:  Yong Qi; Zhenying Nie; Yun-Sik Lee; Neel S Singhal; Philipp E Scherer; Mitchell A Lazar; Rexford S Ahima
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

Review 4.  Endogenous cannabinoid system as a modulator of food intake.

Authors:  D Cota; G Marsicano; B Lutz; V Vicennati; G K Stalla; R Pasquali; U Pagotto
Journal:  Int J Obes Relat Metab Disord       Date:  2003-03

5.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

Authors:  Douglas Osei-Hyiaman; Michael DePetrillo; Pál Pacher; Jie Liu; Svetlana Radaeva; Sándor Bátkai; Judith Harvey-White; Ken Mackie; László Offertáler; Lei Wang; George Kunos
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 6.  Intestinal lipid absorption and transport.

Authors:  C T Phan; P Tso
Journal:  Front Biosci       Date:  2001-03-01

7.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

8.  Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.

Authors:  Tim C Kirkham; Claire M Williams; Filomena Fezza; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

9.  Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.

Authors:  S G Kinsey; J Z Long; S T O'Neal; R A Abdullah; J L Poklis; D L Boger; B F Cravatt; A H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2009-06-05       Impact factor: 4.030

10.  Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice.

Authors:  John D Douglass; Nashmia Malik; Su-Hyoun Chon; Kevin Wells; Yin Xiu Zhou; Andrew S Choi; Laurie B Joseph; Judith Storch
Journal:  Front Physiol       Date:  2012-02-24       Impact factor: 4.566

View more
  29 in total

Review 1.  Genetically modified mouse models to study hepatic neutral lipid mobilization.

Authors:  Guenter Haemmerle; Achim Lass
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-06-05       Impact factor: 5.187

Review 2.  Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes.

Authors:  Theresa D'Aquila; Yu-Han Hung; Alicia Carreiro; Kimberly K Buhman
Journal:  Biochim Biophys Acta       Date:  2016-04-20

Review 3.  Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.

Authors:  Gernot F Grabner; Robert Zimmermann; Rudolf Schicho; Ulrike Taschler
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

4.  Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.

Authors:  Matteo Tardelli; Francesca V Bruschi; Thierry Claudel; Claudia D Fuchs; Nicole Auer; Victoria Kunczer; Tatjana Stojakovic; Hubert Scharnagl; Aida Habib; Gernot F Grabner; Robert Zimmermann; Sophie Lotersztajn; Michael Trauner
Journal:  J Lipid Res       Date:  2019-05-02       Impact factor: 5.922

5.  Effect of liver fatty acid binding protein (L-FABP) gene ablation on lipid metabolism in high glucose diet (HGD) pair-fed mice.

Authors:  Avery L McIntosh; Barbara P Atshaves; Gregory G Martin; Danilo Landrock; Sherrelle Milligan; Kerstin K Landrock; Huan Huang; Stephen M Storey; John Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-03-22       Impact factor: 4.698

6.  Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat.

Authors:  Gregory G Martin; Drew R Seeger; Avery L McIntosh; Sarah Chung; Sherrelle Milligan; Danilo Landrock; Lawrence J Dangott; Mikhail Y Golovko; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Arch Biochem Biophys       Date:  2018-05-12       Impact factor: 4.013

7.  DGAT1 deficiency disrupts lysosome function in enterocytes during dietary fat absorption.

Authors:  Yu-Han Hung; Kimberly K Buhman
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-10-17       Impact factor: 4.698

8.  Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet.

Authors:  Gregory G Martin; Danilo Landrock; Sarah Chung; Lawrence J Dangott; Avery L McIntosh; John T Mackie; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2017-10-02       Impact factor: 5.922

Review 9.  Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine.

Authors:  Harald S Hansen; Vasiliki Vana
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

10.  New Disulfiram Derivatives as MAGL-Selective Inhibitors.

Authors:  Ziad Omran
Journal:  Molecules       Date:  2021-05-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.